Genesis Fertility Center PCL
Genesis Fertility Center PCL maintains a strong liquidity position with a current ratio of 2.77 and cash and equivalents of 130.75 million THB, indicating sufficient short-term financial flexibility. The company's debt-to-equity ratio is 0.05, reflecting a conservative capital structure with minimal leverage. Return on equity (ROE) stands at 3.95%, and return on assets (ROA) is 3.34%, both below the typical thresholds for high-margin healthcare services, suggesting room for improvement in asset utilization and profitability. The company's operating income of 34.76 million THB and net income of 22.40 million THB indicate modest profitability, with a gross margin of 41.7% (147.16 million THB gross profit on 352.99 million THB revenue). These figures suggest the company is generating stable but not exceptional returns, which may be typical for a fertility services provider in a price-sensitive market. Genesis Fertility Center PCL operates through a network of clinics and subsidiaries, including Genosomics Company Limited and GFC Fertility Group Company Limited, and serves both domestic and international patients. The company's revenue is not disclosed by segment or geography, but its international patient base suggests some geographic diversification. The company's revenue of 352.99 million THB reflects a stable operating model, though no specific growth trajectory is provided in the data. Capital expenditures of -41.59 million THB suggest a focus on cost control or asset optimization rather than expansion. Analysts have assigned a single "Hold" recommendation, with no strong buy or buy ratings, indicating a neutral outlook. The company's risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of dilution risk is supported by the fact that basic and diluted shares outstanding are equal at 220 million shares, and no recent equity issuance or ATM/shelf disclosures are noted. No recent filings or transcripts are provided in the data to indicate material events or strategic shifts.
Business. Genesis Fertility Center PCL provides fertility and reproductive healthcare services, including IVF, ICSI, and IUI, to domestic and international patients through its network of clinics and subsidiaries.
Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.
- Genesis Fertility Center PCL maintains a conservative capital structure with a low debt-to-equity ratio of 0.05 and strong liquidity.
- The company's ROE of 3.95% and ROA of 3.34% suggest modest returns, below typical thresholds for high-margin healthcare services.
- The company serves both domestic and international patients, though revenue concentration by geography is not disclosed.
- Analysts have assigned a single "Hold" recommendation, with no strong buy or buy ratings, indicating a neutral outlook.
- The company has no immediate liquidity or dilution risks, with no filing-based flags detected.
- --
- ## RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.